Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceIntermittent preventive treatment for malaria in children living in areas with seasonal transmissionIntermittent preventive antimalarial treatment for children with anaemiaDuration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infantsIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaSubmicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western KenyaDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenDuration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, GhanaFull blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severityModelling the epidemiological impact of intermittent preventive treatment against malaria in infants.Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends.A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysisMolecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern TanzaniaDecline in childhood iron deficiency after interruption of malaria transmission in highland Kenya.Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan AfricaIncreased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.Anti-malarial market and policy surveys in sub-Saharan AfricaEvaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese childrenLow parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western KenyaDrug resistance maps to guide intermittent preventive treatment of malaria in African infants.A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea.Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses.A simple method for defining malaria seasonalityInfluenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants.Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.Socio-economic status is inversely related to bed net use in Gabon.Multi-year optimization of malaria intervention: a mathematical model.The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.Brokering the boundary between science and advocacy: the case of intermittent preventive treatment among infants.Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.
P2860
Q21032450-04810D81-0654-4679-8AD0-594803F2C1B5Q21032527-45F85F57-497C-4999-BF0B-8BFE3D901BE8Q24186627-E5F9C5D2-6EB1-4C83-856D-23356BD9CE9DQ28473083-4820AA29-0307-4213-920F-02640B8E6024Q28473566-4EFF2DB3-46F0-4A97-BDEE-A9070F517336Q28474404-B9150045-8028-4779-BF82-A6E7D9DB1378Q28474692-82A1EEDA-5A5A-4F8E-BD0D-C3EF2CF904B5Q28477679-FD1F91ED-8EFE-448F-B3BA-9B3FEED95DB0Q33336570-B6804E3E-44F1-404F-9702-D6EF35C13569Q33343300-1CEE172F-20EF-4F40-914B-FBE37D622CDFQ33351939-23807EAB-CE1A-4094-ACC3-5825E62BFDE8Q33406496-0EB7D957-74D8-4FD5-9C80-2325EF1D2A5FQ33512921-3EF253F8-E21D-4ACC-8A82-912118B75336Q33529052-A1C86D61-E677-46A5-8161-BCD1CA6B3AA8Q33645358-AA46FDBE-316B-40EF-8ACB-0702BBBDDFD0Q33691573-716E9B5F-2943-461F-A75B-58277A23046FQ33817569-54963F9A-0E34-4B49-81BA-E4B988DFF525Q34056231-7E0DEF37-865C-404C-A457-D713D0B6CE8DQ34128601-D74972E1-28BE-41DA-9302-6E272166E853Q34271078-095C56B3-070D-444A-B468-878672EB5C8EQ34405184-2C7362A5-7D61-4AD9-9181-0EBDC94A1B2AQ34407223-EE782377-C256-4320-BBCD-D8C0917C62C6Q34660009-D5F85E8C-4B63-42C3-B256-9E4A668B56CCQ34960038-7509A32B-8820-4039-A7D1-018D2FAD92C7Q35038632-888E3AF0-ABE5-4FD1-973A-6A6CB03B2D93Q35224777-80E3A575-D3A8-4D7C-B2F4-CD484F0AB18AQ35228689-840A18D5-2F01-4C96-A9D3-053DFB5B8E7AQ35549781-DBE44B54-937A-488F-9420-8B11783A2240Q35573556-460CA13D-9C58-493F-B161-65A9ED244065Q35573781-D21A9245-0CDA-4187-91D8-63A5C1A80CDBQ35575256-A75C0DF9-4080-4B3E-BD31-DDF41900673FQ35934042-8A8945FD-F4F7-4D08-B745-6EA82893B704Q36018719-E481F5EB-C43C-42BD-8C56-16B7A111DE02Q36606694-2B590DE4-34D3-41F1-A3A4-FCD0A72393BFQ36639299-B135CBF5-0B37-4FCF-B24A-AE1E6036E576Q36958924-AB96D54E-8F44-4EEE-AE3E-74A759A499B6Q36981978-5066A8A3-2283-4D34-9598-8CDAB12F5C7DQ37107195-5E5F4011-2BE9-409F-97E8-F591D251860DQ37122802-12C765A9-200A-4AC1-A881-C52E793527C6Q37325652-026E3EE2-7CBA-41DA-B58E-5E5B482E9F59
P2860
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intermittent preventive treatm ...... ind, placebo-controlled trial.
@en
type
label
Intermittent preventive treatm ...... ind, placebo-controlled trial.
@en
prefLabel
Intermittent preventive treatm ...... ind, placebo-controlled trial.
@en
P2093
P50
P921
P356
P1476
Intermittent preventive treatm ...... ind, placebo-controlled trial.
@en
P2093
Akim A Adegnika
Anna Klopfer
Benjamin Naumann
Carmen L Ospina Salazar
Christian Supan
Davy U Kombila
Georg C Kiessling
Handan Altun
Isabelle von Glasenapp
Jenny Dornemann
P304
P356
10.1086/522160
P407
P577
2007-10-25T00:00:00Z